Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOTHER Trial: Efficacy and Safety of Low-dose Intrathecal Morphine Following Planned Caesarean Section - a Randomised, Blinded, Clinical, Controlled, Multicentre Trial.

NCT06797973 is registered in ClinicalTrials.gov with Anne Juul Wikkelsø as lead sponsor.

NCT NCT06797973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06797973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOTHER Trial: Efficacy and Safety of Low-dose Intrathecal Morphine Following Planned Caesarean Section - a Randomised, Blinded, Clinical, Controlled, Multicentre Trial.
Lead sponsor
Anne Juul Wikkelsø
Phase
Phase 4
Overall status
Recruiting
Start date
July 15, 2025
Completion date
June 30, 2027
Enrollment
1,312 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

caesarean section, postoperative pain